Circular ASOs: Exploring Chemistry Behind the Next Wave of Antisense Innovation
9:00 am - Thursday 10th December 2026
- Explore the chemistry behind circularised antisense oligonucleotides and understand how these designs differ from conventional linear gapmer ASOs
- Evaluate whether circularisation can meaningfully improve stability, pharmacokinetics and therapeutic durability compared with existing antisense approaches
- Gain deeper technical insight into an emerging chemistry platform that has rapidly gained industry attention but remains relatively unexplored from a development perspective
